LINICAL ACCELOVANCE EUROPE BV - NL 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2016 0 6.001.482 1.022.313 1
2015 0 5.855.219 314.026 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
STICHTING VU2
STICHTING VUMC2
ACADEMISCH ZIEKENHUIS GRONINGEN1
BEYONDEVICES LDA1
BIONTECH INNOVATIVE MANUFACTURING SERVICES1
BLUEPHARMA INDUSTRIA FARMACEUTICASA1
CENTRO HOSPITALAR E UNIVERSITARIO DE COIMBRA EPE1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CURVE CLINICAL BV1
DCPRIME BV1
HELSE BERGEN HFHAUKELAND UNIVERSITY HOSPITAL1
HELSINGIN YLIOPISTO1
IMMATICS BIOTECHNOLOGIES1
NARODNY USTAV REUMATICKYCH CHOROBNURCH NIRD NATIONAL INSTITUTE OF RHEUMATIC DISEASES1
STICHTING TOOLS1
TECHNISCHE UNIVERSITAET DRESDEN1
UNIVERSITA DEGLI STUDI DI GENOVA1
UNIVERSITAETSKLINIKUM BONN1
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ1
UNIVERSITATEA DE MEDICINA SI FARMACIE'CAROL DAVILA' DIN BUCURESTI1
UNIVERSITETET I BERGEN1
UNIVERSITY OF DEBRECEN1
UPPSALA UNIVERSITET1

Constancy:

Total number of partners: 25
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 25
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2016-01-01Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia AML-VACCiNparticipant6.001.48214
2015-09-01Comparing the effectiveness and safety of additional low-dose glucocorticoid in treatment strategies for elderly patients with rheumatoid arthritis GLORIAparticipant5.855.21913